DiaSorin (OTCMKTS:DSRLF) Earns Equal Weight Rating from Analysts at Barclays

Stock analysts at Barclays initiated coverage on shares of DiaSorin (OTCMKTS:DSRLF) in a research note issued to investors on Thursday, Briefing.com reports. The firm set an “equal weight” rating on the stock.

DiaSorin Price Performance

Shares of OTCMKTS DSRLF opened at $107.40 on Thursday. The company’s fifty day moving average price is $94.74 and its 200 day moving average price is $94.68. DiaSorin has a 1 year low of $86.00 and a 1 year high of $120.00.

DiaSorin Company Profile

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.